deCODE genetics Uncovers Impact of Mutations in The Human Genome on Cognitive Ability
REYKJAVIK, Iceland, Dec. 18, 2013 - deCODE genetics, a global leader in analyzing and understanding the human genome, reported today in the journal Nature that mutations associated with an increased risk of schizophrenia and autism also affect cognition in individuals...
A Mutation Discovered in Iceland that Increases Risks of Osteoporosis and Certain Cancers
Nature Published Study Illustrates Value of Big Data Research Methods deCODE genetics (an Amgen subsidiary) and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and the University...
Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
deCODE Genetics Will Provide Amgen With an Industry-Leading Ability to Identify and Validate Disease Targets in Human Populations THOUSAND OAKS, Calif. and REYKJAVIK, Iceland, Dec. 10, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and deCODE Genetics today announced that...
deCODE Genetics, Multinational Research Team Find Gene Variant Conferring High Risk for Common, Late-Onset Form of Alzheimer’s Disease
Findings Published in New England Journal of Medicine Provide New Focus for Drug Discovery Study Demonstrates Power of “Big Data” Research REYKJAVIK, Iceland - deCODE Genetics and Illumina, global leaders in analyzing and understanding the human genome, together with...
UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.